Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ACD-856 by AlzeCure Pharma for Depression: Likelihood of Approval
ACD-856 is under clinical development by AlzeCure Pharma and currently in Phase I for Depression. According to GlobalData, Phase I...